Integra LifeSciences Holdings Corporation (IART)

NASDAQ: IART · IEX Real-Time Price · USD

29.38

+0.40 (1.38%)

At close: Apr 23, 2024, 4:00 PM

29.35

-0.03 (-0.10%)

After-hours: Apr 23, 2024, 5:19 PM EDT

IART Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1995
Cash & Equivalents	276.4	456.66	513.45	470.17	198.91	138.84	174.94	102.06	52.21	71.73	Upgrade
Short-Term Investments	32.69	0	0	0	0	0	0	0	0	0	Upgrade
Cash & Cash Equivalents	309.1	456.66	513.45	470.17	198.91	138.84	174.94	102.06	52.21	71.73	Upgrade
Cash Growth	-32.31%	-11.06%	9.21%	136.37%	43.27%	-20.63%	71.41%	95.49%	-27.22%	-40.53%	Upgrade
Receivables	259.33	263.47	231.83	225.53	275.3	265.74	251.8	148.19	132.24	110.41	Upgrade
Inventory	389.61	324.58	317.39	310.12	316.05	280.35	296.33	217.26	211.43	189.13	Upgrade
Other Current Assets	100.01	116.79	91.05	231.39	67.91	90.16	99.08	27.67	42.62	158.04	Upgrade
Total Current Assets	1,058	1,161	1,154	1,237	858.17	775.08	822.15	495.17	438.5	529.32	Upgrade
Property, Plant & Equipment	496.38	459.59	396.25	371.16	431.93	300.11	269.25	222.37	205.18	193.63	Upgrade
Goodwill and Intangibles	2,123	2,165	2,159	1,922	1,986	2,006	2,098	1,072	1,116	776.05	Upgrade
Other Long-Term Assets	104.27	103.18	73.39	84.97	27.27	26.72	22.33	18.67	14.42	88.43	Upgrade
Total Long-Term Assets	2,724	2,728	2,629	2,378	2,445	2,333	2,389	1,313	1,336	1,058	Upgrade
Total Assets	3,782	3,890	3,782	3,615	3,303	3,108	3,211	1,808	1,774	1,587	Upgrade
Accounts Payable	92.33	102.1	61.84	54.61	113.09	76.05	93.97	29.06	34.77	28.87	Upgrade
Deferred Revenue	8.54	7.25	5.3	5.28	4.77	3.76	11.05	6.81	5.67	5.18	Upgrade
Current Debt	29.82	52.75	59.78	159.07	57.25	22.5	60	0	14.38	3.75	Upgrade
Other Current Liabilities	176.3	158.8	213.11	182.06	156.19	160.24	183.89	87.73	84.31	88.23	Upgrade
Total Current Liabilities	306.98	320.91	340.02	401.01	331.31	262.55	348.91	123.6	139.13	126.03	Upgrade
Long-Term Debt	1,652	1,563	1,592	1,496	1,401	1,332	1,781	665	700.12	626.25	Upgrade
Other Long-Term Liabilities	235.26	201.84	166.05	202.92	154.63	137.83	118.9	179.69	183.54	130.83	Upgrade
Total Long-Term Liabilities	1,887	1,764	1,758	1,699	1,555	1,470	1,900	844.69	883.65	757.07	Upgrade
Total Liabilities	2,194	2,085	2,098	2,100	1,887	1,732	2,249	968.29	1,023	883.1	Upgrade
Total Debt	1,682	1,615	1,651	1,655	1,458	1,354	1,841	665	714.49	630	Upgrade
Debt Growth	4.11%	-2.18%	-0.25%	13.55%	7.65%	-26.45%	176.86%	-6.93%	13.41%	60.69%	Upgrade
Retained Earnings	946.86	879.12	698.57	532.27	398.57	348.37	285.19	220.44	145.88	314.96	Upgrade
Comprehensive Income	-15.11	10.27	-45.16	-74.06	-76.4	-45.44	-23.81	-57.15	-47.9	-23.49	Upgrade
Shareholders' Equity	1,588	1,804	1,685	1,515	1,417	1,376	962.31	839.67	751.44	704.32	Upgrade
Net Cash / Debt	-1,372.59	-1,158.7	-1,137.84	-1,185.24	-1,258.91	-1,215.38	-1,666.21	-562.95	-662.29	-558.26	Upgrade
Net Cash Per Share	-17.09	-13.87	-13.31	-13.91	-14.55	-14.47	-21.06	-7.11	-9.28	-8.47	Upgrade
Working Capital	751.06	840.59	813.7	836.19	526.86	512.53	473.24	371.57	299.37	403.3	Upgrade
Book Value Per Share	19.83	21.74	19.89	17.90	16.54	16.60	12.51	11.29	10.89	10.86	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).